- Home
- CLGN vs RPTX Comparison
CLGN vs RPTX Comparison
Compare CLGN & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- RPTX
- Stock Information
- Founded
- CLGN 2004
- RPTX 2016
- Country
- CLGN Israel
- RPTX Canada
- Employees
- CLGN N/A
- RPTX N/A
- Industry
- CLGN Industrial Specialties
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLGN Health Care
- RPTX Health Care
- Exchange
- CLGN Nasdaq
- RPTX Nasdaq
- Market Cap
- CLGN 37.4M
- RPTX 38.3M
- IPO Year
- CLGN N/A
- RPTX 2020
- Fundamental
- Price
- CLGN $1.82
- RPTX $1.36
- Analyst Decision
- CLGN Strong Buy
- RPTX Strong Buy
- Analyst Count
- CLGN 2
- RPTX 3
- Target Price
- CLGN $12.50
- RPTX $4.50
- AVG Volume (30 Days)
- CLGN 12.7K
- RPTX 503.0K
- Earning Date
- CLGN 05-28-2025
- RPTX 05-20-2025
- Dividend Yield
- CLGN N/A
- RPTX N/A
- EPS Growth
- CLGN N/A
- RPTX N/A
- EPS
- CLGN N/A
- RPTX N/A
- Revenue
- CLGN $515,000.00
- RPTX $53,477,000.00
- Revenue This Year
- CLGN $2,177.67
- RPTX N/A
- Revenue Next Year
- CLGN $56.52
- RPTX $7.14
- P/E Ratio
- CLGN N/A
- RPTX N/A
- Revenue Growth
- CLGN N/A
- RPTX 4.58
- 52 Week Low
- CLGN $1.82
- RPTX $0.89
- 52 Week High
- CLGN $6.75
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- CLGN 23.18
- RPTX 59.23
- Support Level
- CLGN $2.00
- RPTX $1.31
- Resistance Level
- CLGN $2.40
- RPTX $1.48
- Average True Range (ATR)
- CLGN 0.21
- RPTX 0.10
- MACD
- CLGN -0.01
- RPTX 0.00
- Stochastic Oscillator
- CLGN 3.59
- RPTX 57.14
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.